Allopurinol Tablet
Product Images NDC 43063-975

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43063-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063975 Label (43063975)

This is a prescription drug package for Allopurinol tablets, which are used to prevent gout and kidney stones. The package contains 90 tablets of 100 mg each. The drug is to be taken a certain number of times a day as advised by the doctor. This is a potent drug, and it should be kept out of the reach of children. The drug may have some side effects, which should be reported to the doctor immediately. The user should read the package insert carefully before using the drug. It also contains expiry date and reorder numbers.*

FDA Label Image

Structure (Allopurinol 01)

FDA Label Image

Figure (Allopurinol 02)

Allopurinol is a medication that is converted into a compound called oxipurinol. The chemical structure of allopurinol and oxipurinol is a dihydro-4Hpyrazolo [3,4-d]pyrimidin-dione and a pyrimidine, 4.6-(1H,7H)-dione, respectively. Allopurinol and oxipurinol work to reduce levels of hypoxanthine, xanthine, and uric acid in the body. Hypoxanthine is a purine derivative that can be converted into xanthine and then into uric acid. Uric acid is the end product of purine metabolism.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.